Bengaluru-based biotech firm, Azooka, celebrated its 10 year mikestone on Feb 27, hosting its user conference, Bioverse 2026, which focused on the interconnected nature of next-generation healthtech.

The collaborations will provide Illumina's customers with workflows for genomic disease characterization and spatial mapping.

Researchers at the Weill Institute for Cell and Molecular Biology have uncovered new evidence that two major types of gene-controlling DNA sequences, promoters and enhancers, operate with a shared ...

By Dusty Vyas, Senior Scientist at LGC Biosearch Technologies Targeted GBS  The application of targeted genotyping by sequencing (targeted GBS) in | Genetics And Genomics ...

Identical stool samples sent to seven direct-to-consumer microbiome testing companies produced substantially different ...

Twice the output, half the runtime, and half the footprint of the UG 100® with greater flexibility and improved genomic ...

The UPLC system was configured with an Acquity Premier Oligonucleotide C18 column (1.7 µm, 2.1 × 50 mm). The aqueous and ...

Advancements in genetics testing in the clinic may allow for faster diagnosis and treatments, say genetics experts at Johns ...

Reduce amplification bias caused by variable miRNA abundance using automated PCR normalization for NEXTFLEX small RNA sequencing workflows.

A proposed function of TADs is to contribute to gene regulation by promoting chromatin interactions within a TAD and by suppressing interactions between TADs. Here, we directly probe the ...

Gene therapies have the potential to cure some diseases, but they are extraordinarily expensive. Location can also be a big ...